What Is TMO Fair Value?
Thermo Fisher Scientific Inc. (TMO) fair value estimate using multiple valuation models, updated daily.
As of September 15, 2026, Thermo Fisher Scientific Inc. (TMO) has a composite fair value estimate of $283.13 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $641.39, suggesting the stock is overvalued by 55.9%.
Data as of September 15, 2026 (today)
Composite Fair Value
Overvalued4 of 4 models$283.13
vs. current price of $641.39(-55.9%)
How Is TMO Fair Value Calculated?
Four independent models estimate what TMO is worth. Each uses different inputs and assumptions. The composite blends them by weight.
TMO Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
35% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$346.13
-46.0%Overvalued
Inputs used
DDM (Dividend Discount Model)
15% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
$45.45
-92.9%Overvalued
Inputs used
TMO Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
25% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$283.84
-55.7%Overvalued
Inputs used
PEG (Price/Earnings to Growth)
25% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$251.31
-60.8%Overvalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $641.39 is 46.0% above this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $6.84B | $6.31B |
| Year 2 | $7.51B | $6.39B |
| Year 3 | $8.24B | $6.47B |
| Year 4 | $9.04B | $6.55B |
| Year 5 | $9.92B | $6.63B |
| Year 6 | $10.88B | $6.71B |
| Year 7 | $11.94B | $6.79B |
| Year 8 | $13.10B | $6.87B |
| Year 9 | $14.37B | $6.96B |
| Year 10 | $15.77B | $7.04B |
| Terminal Value | $274.04B | $122.34B |
What Are TMO's Key Financial Metrics?
Earnings & Growth
Current Price
$641.39
EPS (TTM)
$18.59
Forward P/E
23.3
Profit Margin
15.0%
Cash & Balance Sheet
Free Cash Flow
6.2B
EBITDA
11.7B
Book Value
$142.47
Total Debt
42.5B
What Do Analysts Say About TMO?
Low
$520.00
Average
$645.15
High
$750.00
Upside
+0.6%
TMO Fair Value FAQ
What is the fair value of TMO?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), TMO's estimated fair value is $283.13. The stock is currently trading at $641.39, which makes it overvalued by our analysis.
How is TMO's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is TMO overvalued or undervalued?
Based on our analysis, TMO is overvalued. The current price of $641.39 is 55.9% above our estimated fair value of $283.13.
What do Wall Street analysts say about TMO?
27 analysts cover Thermo Fisher Scientific Inc. with a consensus rating of "Buy." The average price target is $645.15, ranging from $520.00 to $750.00. This implies 0.6% upside from the current price.